HomeCompareCVTGF vs JNJ

CVTGF vs JNJ: Dividend Comparison 2026

CVTGF yields 1.32% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CVTGF wins by $92.4K in total portfolio value
10 years
CVTGF
CVTGF
● Live price
1.32%
Share price
$49.00
Annual div
$0.65
5Y div CAGR
60%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$122.7K
Annual income
$52,188.01
Full CVTGF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — CVTGF vs JNJ

📍 CVTGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCVTGFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CVTGF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CVTGF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CVTGF
Annual income on $10K today (after 15% tax)
$112.55/yr
After 10yr DRIP, annual income (after tax)
$44,359.81/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, CVTGF beats the other by $40,373.82/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CVTGF + JNJ for your $10,000?

CVTGF: 50%JNJ: 50%
100% JNJ50/50100% CVTGF
Portfolio after 10yr
$76.5K
Annual income
$28,438.71/yr
Blended yield
37.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CVTGF
No analyst data
Altman Z
5.5
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CVTGF buys
0
JNJ buys
0
No recent congressional trades found for CVTGF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCVTGFJNJ
Forward yield1.32%2.13%
Annual dividend / share$0.65$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR60%28%
Portfolio after 10y$122.7K$30.3K
Annual income after 10y$52,188.01$4,689.40
Total dividends collected$96.1K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CVTGF vs JNJ ($10,000, DRIP)

YearCVTGF PortfolioCVTGF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,912$211.86$10,592$272.30+$320.00CVTGF
2$12,021$345.69$11,289$357.73+$732.00CVTGF
3$13,432$569.48$12,123$472.89+$1.3KCVTGF
4$15,324$951.52$13,141$629.86+$2.2KCVTGF
5$18,020$1,623.21$14,408$846.81+$3.6KCVTGF
6$22,136$2,854.25$16,021$1,151.60+$6.1KCVTGF
7$28,928$5,242.83$18,122$1,588.22+$10.8KCVTGF
8$41,198$10,245.36$20,930$2,228.20+$20.3KCVTGF
9$65,901$21,818.47$24,792$3,191.91+$41.1KCVTGF
10$122,702$52,188.01$30,274$4,689.40+$92.4KCVTGF

CVTGF vs JNJ: Complete Analysis 2026

CVTGFStock

Clairvest Group Inc. is a private equity firm specializing in mid-market, growth equity investments, growth capital, buyouts, and consolidating industries and add-on acquisitions. It seeks to invest in small and mid-sized gaming and casino, local market gaming, healthcare, equipment rental, facility services, oilfield services, waste management, business services, consumer services, aerospace, automotive aftermarket, collision repair, food, beverage and co-packing, defense, document management, warranty, contact manufacturing, environmental services, rental services, residential HVAC services, healthcare services, multiunit healthcare, insurance services, IT services, logistics and transportation, mining services, packaging, pest control, specialty aviation, education, software (mature), textile rental, utility services, water, building products, government services, industrial distribution and services, information technology and information services, media and marketing, non-destructive testing, renewable energy, property management, and restaurants. The firm typically invests in companies based in North America including United States and Canada. It seeks to make equity investments between CAD$25 million ($19.53 million) and CAD$100 million ($78.14 million) in its portfolio company with EBITDA between CAD$5 million ($3.81 million) and CAD$50 million ($39.07 million). The firm does not require majority stake and takes controlling or minority investments. It invests its own capital and seeks to take a board seat on its portfolio companies. The firm also makes co-investments. The firm typically exits its investments through market share offering, a strategic sale or sale to a financial buyer. Clairvest Group Inc. was founded in 1987 and is based in Toronto, Canada.

Full CVTGF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CVTGF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CVTGF vs SCHDCVTGF vs JEPICVTGF vs OCVTGF vs KOCVTGF vs MAINCVTGF vs ABBVCVTGF vs MRKCVTGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.